Obesity is a worldwide epidemic and in the United States alone, 60% of adults are obese or overweight.1 Those struggling with obesity are at a higher risk of developing cardiovascular disease, cancer, and diabetes.2 We’re proud to provide patients struggling with obesity in San Marcos, Menifee, Mission Valley, Encinitas, and National City with non-surgical weight loss options. If you want to take action but aren’t ready to undergo, or aren’t a candidate for, surgical intervention, weight loss injections may be right for you.
Benefits of GLP-1
Along with helping to boost weight loss and control blood sugar, GLP-1 seems to have other significant benefits. Research has found that some drugs in these classes of medications may lower the risk of heart disease, including heart failure, stroke, and kidney disease. People taking these drugs have seen improvements in their blood pressure and cholesterol levels, though it’s not clear whether these benefits are from the medication or weight loss.
How Much Weight Will I Lose With Weight Loss Injections?
Weight loss with GLP-1 can vary, patients average 3 to 5 pounds of weight loss per month with weight loss injections alone, however, those who incorporate healthy lifestyle changes including a balanced diet and regular physical activity may lose more.
When coupled with a healthy lifestyle, research has shown that the weight loss injections with GLP-1 can result in an additional 6 to 9 pounds of additional weight loss per month. After your initial visit with your Before-N-After provider, you will meet once a week with a clinician to review your results and optimize your program as necessary.
Does GLP-1 Have Any Side Effects?
Before-N-After offers GLP-1 by injection, and, like any medication, there is a risk of side effects. However, common side effects usually improve after you’ve taken the medication for a while and your Before-N-After provider can suggest remedies that may lessen these symptoms. The most common side effect associated with GLP-1 is nausea. This is best controlled by making small, incremental changes in dosing. The feedback you provide to your provider will determine your dosing increases. The most serious risk posed by GLP-1 class medications is low blood sugar levels (hypoglycemia). But this is the result of taking another medication known to lower blood sugar while also taking GLP-1, such as sulfonylureas or insulin.
Less common side effects include belching, constipation, diarrhea, and fatigue. However, most side effects improve by weeks 4-6. In addition, GLP-1 has also been associated with a slight increase in gallstones, and low blood sugar (hypoglycemia) in Type 2 diabetics who take insulin and medications known as sulfonylurea’s (Glyburide, Glimepiride, Glipizide).
GLP-1 Injection Treatment Tiers
We offer a range of treatment tiers designed with you in mind. We know that every patient is unique and therefore each treatment plan is highly customizable. Each uses different doses of GLP-1 and falls into a range of costs between $65 – $150. These costs are weekly, as patients receive one injection per week.
- Slim Startup Program
- Slim Program
- Slim Plus Program
- Slim Extra Plus Program
- Slim Max Program
Candidates For GLP-1 Weight Loss Injections
In general, GLP-1 is intended for individuals looking to augment a healthy lifestyle with a weight loss medication that can accelerate weight loss. The GLP-1 class of drugs isn’t recommended if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias as well as those who have an allergy to GLP-1 medications, a history of pancreatitis, are breastfeeding, or may be pregnant. In addition, patients already taking a GLP-1 or sulfonylurea mediation such as Dulaglutide (Trulicity), Semaglutide (Ozempic), Semaglutide (Rybelsus) should not take GLP-1.
1 Gastroenterology & Hepatology. The Obesity Epidemic: Challenges, Health Initiatives, and Implications for Gastroenterologists. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033553/. Accessed June 14, 2022.
2 AHA Journals. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Available: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000973. Accessed June 14, 2022.
The Medical Professionals at Before-N-After have either authored or reviewed and approved this content.